In The news
IBJ News: FDA Upheaval Worries Local Companies
Source: Indianapolis Business Journal
The Trump administration’s decision to cut 3,500 FDA jobs is stirring concern among Indianapolis-based companies that rely on the agency for product approvals and regulatory clarity. While federal officials say inspections and reviews will be unaffected, local medical device and software firms report anxiety over potential delays, investor hesitation, and confusion about shifting FDA protocols—especially around AI-enabled technologies. Health tech leaders from Greenlight Guru, Boomerang Ventures, and Eagle Creek Consultants weigh in on the ripple effects of the shakeup.
04/11/2025